The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Site maintenance Monday, July 8th, 2024. Please note that access to some content and account information will be unavailable on this date.
PsychopharmacologyFull Access

Diagnosing and Treating DMDD

Published Online:

Abstract

Studies suggest that approximately 1 to 3 percent of children under the age of 10 display symptoms of disruptive dysregulation mood disorder.

Photo: Ellen Leibenluft, M.D.

Ellen Leibenluft, M.D., says that clinicians must rely on literature to guide them on how best to treat disruptive mood dysregulation disorder (DMDD).

National Institute of Mental Health

Because disruptive mood dysregulation disorder (DMDD) is a relatively new mental health diagnosis, there is not much information readily available for those psychiatrists who would like to know more about the disorder, particularly as it relates diagnosing and treating. Ellen Leibenluft, M.D., a senior Investigator and Chief of the Section on Bipolar Spectrum Disorders at the National Institute of Mental Health, gives an overview of diagnosis and treatment for the mental health disorder.

To listen to an interview with Ellen Leibenluft, M.D., click here.■